1887

Abstract

In this study, the mechanisms leading to increased chromosomal AmpC -lactamase expression and the contributory roles of the outer-membrane protein OprF and penicillin-binding proteins were analysed in 33 characterized clinical isolates of . The genes and were analysed by PCR and DNA sequencing. Expression of the gene was assessed using real-time RT-PCR, and penicillin-binding proteins were analysed using a chemiluminescence assay. Several of the isolates with increased expression had major deletions affecting , although in some isolates the mechanism of increased expression could not be ascertained. Occasional isolates had increased expression of both and but remained susceptible to cephalosporins, suggesting that increased -lactamase activity could not offset increased outer-membrane permeability. There were no discernible changes in penicillin-binding proteins. Genomic deletions in were observed in selected clinical isolates of with increased expression of the AmpC -lactamase. For some isolates, cephalosporin resistance was dependent upon the interplay of and expression.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.47019-0
2007-06-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/jmm/56/6/809.html?itemId=/content/journal/jmm/10.1099/jmm.0.47019-0&mimeType=html&fmt=ahah

References

  1. Bagge N., Ciofu O., Hentzer M., Campbell J. I. A., Givskov M., Høiby N. 2002; Constitutive high expression of chromosomal β -lactamase in Pseudomonas aeruginosa caused by a new insertion sequence (IS 1669 ) located in ampD . Antimicrob Agents Chemother 46:3406–3411 [CrossRef]
    [Google Scholar]
  2. Bellido F., Martin N. L., Siehnel R. J., Hancock R. E. 1992; Reevaluation, using intact cells, of the exclusion limit and role of porin OprF in Pseudomonas aeruginosa outer membrane permeability. J Bacteriol 174:5196–5203
    [Google Scholar]
  3. Brinkman F. S. L., Schoofs G., Hancock R. E. W., De Mot R. 1999; Influence of a putative ECF sigma factor on expression of the major outer membrane protein, OprF, in Pseudomonas aeruginosa and Pseudomonas fluorescens . J Bacteriol 181:4746–4754
    [Google Scholar]
  4. Brinkman F. S. L., Bains M., Hancock R. E. W. 2000; The amino terminus of Pseudomonas aeruginosa outer membrane protein OprF forms channels in lipid bilayer membranes: correlation with a three-dimensional model. J Bacteriol 182:5251–5259 [CrossRef]
    [Google Scholar]
  5. Campbell J. I. A., Ciofu O., Hoiby N. 1997; Pseudomonas aeruginosa isolates from patients with cystic fibrosis have different β -lactamase expression phenotypes but are homogeneous in the ampC–ampR genetic region. Antimicrob Agents Chemother 41:1380–1384
    [Google Scholar]
  6. Chamberland S., Malouin F., Rabin H. R., Schollaardt T., Parr T. R. Jr, Bryan L. E. 1990; Persistence of Pseudomonas aeruginosa during ciprofloxacin therapy of a cystic fibrosis patient: transient resistance to quinolones and protein F-deficiency. J Antimicrob Chemother 25:995–1010 [CrossRef]
    [Google Scholar]
  7. Curtis N. A. C., Orr D., Ross G. W., Boulton M. G. 1979; Competition of β -lactam antibiotics for the penicillin-binding proteins of Pseudomonas aeruginosa , Enterobacter cloacae , Klebsiella aerogenes , Proteus rettgeri , and Escherichia coli : comparison with antibacterial activity and effects upon bacterial morphology. Antimicrob Agents Chemother 16:325–328 [CrossRef]
    [Google Scholar]
  8. Godfrey A. J., Bryan L. E., Rabin H. R. 1981; β -Lactam-resistant Pseudomonas aeruginosa with modified penicillin-binding proteins emerging during cystic fibrosis treatment. Antimicrob Agents Chemother 19:705–711 [CrossRef]
    [Google Scholar]
  9. Gotoh N., Wakebe H., Yoshihara E., Nakae T., Nishino T. 1989; Role of protein F in maintaining structural integrity of the Pseudomonas aeruginosa outer membrane. J Bacteriol 171:983–990
    [Google Scholar]
  10. Hancock R. E. W., Woodruff W. A. 1988; Roles of porin and β -lactamase in β -lactam resistance of Pseudomonas aeruginosa . Rev Infect Dis 10:770–775 [CrossRef]
    [Google Scholar]
  11. Juan C., Macia M. D., Gutierrez O., Vidal C., Pérez J. L., Oliver A. 2005; Molecular mechanisms of β -lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains. Antimicrob Agents Chemother 49:4733–4738 [CrossRef]
    [Google Scholar]
  12. Juan C., Moya B., Perez J. L., Oliver A. 2006; Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring high-level β -lactam resistance involves three AmpD homologues. Antimicrob Agents Chemother 50:1780–1787 [CrossRef]
    [Google Scholar]
  13. Kong K.-F., Jayawardena S. R., Indulkar S. D., del Puerto A., Koh C.-L., Høiby N., Mathee K. 2005; Pseudomonas aeruginosa AmpR is a global transcriptional factor that regulates expression of AmpC and PoxB β -lactamases, proteases, quorum sensing, and other virulence factors. Antimicrob Agents Chemother 49:4567–4575 [CrossRef]
    [Google Scholar]
  14. Langaee T. Y., Gagnon L., Huletsky A. 2000; Inactivation of the ampD gene in Pseudomonas aeruginosa leads to moderate-basal-level and hyperinducible AmpC β -lactamase expression. Antimicrob Agents Chemother 44:583–589 [CrossRef]
    [Google Scholar]
  15. Nikaido H., Nikaido K., Harayama S. 1991; Identification and characterization of porins in Pseudomonas aeruginosa . J Biol Chem 266:770–779
    [Google Scholar]
  16. Noguchi H., Matsuhashi M., Mitsuhashi S. 1979; Comparative studies of penicillin-binding proteins in Pseudomonas aeruginosa and Escherichia coli . Eur J Biochem 100:41–49 [CrossRef]
    [Google Scholar]
  17. Noguchi H., Fukasawa M., Komatsu T., Mitsuhashi S., Matsuhashi M. 1985; Mutation in Pseudomonas aeruginosa causing simultaneous defects in penicillin-binding protein 5 and in enzyme activities of penicillin release and d-alanine carboxypeptidase. J Bacteriol 162:849–851
    [Google Scholar]
  18. Piddock L. J. V., Hall M. C., Bellido F., Bains M., Hancock R. E. 1992; A pleiotropic, posttherapy, enoxacin-resistant mutant of Pseudomonas aeruginosa . Antimicrob Agents Chemother 36:1057–1061 [CrossRef]
    [Google Scholar]
  19. Pucci M. J., Boice-Sowek J., Kessler R. E., Dougherty T. J. 1991; Comparison of cefepime, cefpirome, and cefaclidine binding affinities for penicillin-binding proteins in Escherichia coli K-12 and Pseudomonas aeruginosa SC8329. Antimicrob Agents Chemother 35:2312–2317 [CrossRef]
    [Google Scholar]
  20. Quale J., Bratu S., Landman D., Heddurshetti R. 2003; Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin Infect Dis 37:214–220 [CrossRef]
    [Google Scholar]
  21. Quale J., Bratu S., Gupta J., Landman D. 2006; Interplay of efflux system, ampC , and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 50:1633–1641 [CrossRef]
    [Google Scholar]
  22. Quinn J. P., Dudek E. J., DiVincenzo C. A., Lucks D. A., Lerner S. A. 1986; Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections. J Infect Dis 154:289–294 [CrossRef]
    [Google Scholar]
  23. Rawling E. G., Brinkman F. S. L., Hancock R. E. W. 1998; Roles of the carboxy-terminal half of Pseudomonas aeruginosa major outer membrane protein OprF in cell shape, growth in low-osmolarity medium, and peptidoglycan association. J Bacteriol 180:3556–3562
    [Google Scholar]
  24. Woodruff W. A., Hancock R. E. W. 1988; Construction and characterization of Pseudomonas aeruginosa protein F-deficient mutants after in vitro and in vivo insertion mutagenesis of the cloned gene. J Bacteriol 170:2592–2598
    [Google Scholar]
  25. Woodruff W. A., Hancock R. E. W. 1989; Pseudomonas aeruginosa outer membrane protein F: structural role and relationship to the Escherichia coli OmpA protein. J Bacteriol 171:3304–3309
    [Google Scholar]
  26. Yoshihara E., Nakae T. 1989; Identification of porins in the outer membrane of Pseudomonas aeruginosa that form small diffusion pores. J Biol Chem 264:6297–6301
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.47019-0
Loading
/content/journal/jmm/10.1099/jmm.0.47019-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error